Prosecution Insights
Last updated: April 19, 2026

Examiner: RODRIGUEZ-GARCIA, VALERIE

Tech Center 1700 • Art Units: 1621 1622 1626 1759

This examiner grants 69% of resolved cases

Performance Statistics

68.8%
Allow Rate
+3.8% vs TC avg
846
Total Applications
+31.6%
Interview Lift
936
Avg Prosecution Days
Based on 811 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
24.5%
§102 Novelty
22.3%
§103 Obviousness
36.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16807102 METHODS FOR TREATING PROTEINOPATHIES Non-Final OA Genzyme Corporation
18257920 METHODS FOR CONTROLLING OR PREVENTING INFESTATION OF PLANTS BY A PHYTOPATHOGENIC MICROORGANISM OF THE GENUS ASPERGILLUS Final Rejection SYNGENTA CROP PROTECTION AG
18522929 USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS Final Rejection DANA-FARBER CANCER INSTITUTE, INC.
18802247 COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGRADATION Non-Final OA University of Kentucky Research Foundation
18995166 PROCESSES FOR PRODUCING NITRILES AND PHOSPHORUS-CONTAINING CATALYSTS FOR USE IN SUCH PROCESSES Non-Final OA INV NYLON CHEMICALS AMERICAS, LLC
18184249 METHOD FOR DETECTION OF MICROORGANISMS Non-Final OA Ramot at Tel-Aviv University Ltd.
17771732 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES Final Rejection Bayer Aktiengesellschaft
18272221 GLYCIDYL (METH)ACRYLATE COMPOSITION Non-Final OA MITSUBISHI GAS CHEMICAL COMPANY, INC.
18766386 DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS Non-Final OA Viotika Life Sciences Inc.
18737889 COMPOUNDS, COMPOSITIONS AND METHODS OF USE FOR NICOTINE CESSATION AND CHEMOPREVENTION Final Rejection PACIFIC UNIVERSITY
18520444 CINNAMALDEHYDE DERIVATIVE COMPOUNDS AND METHODS OF USE FOR CINNAMALDEHYDE DERIVATIVE COMPOUNDS NICOTINE CESSATION Final Rejection PACIFIC UNIVERSITY
18248441 IMPROVED FOAMING BIOSURFACTANTS Non-Final OA LOCUS SOLUTIONS IPCO, LLC
18250516 PROCESS FOR REFINING GLYCOLIDE AND GLYCOLIDE OBTAINED THEREFROM Non-Final OA SHANGHAI RESEARCH INSTITUTE OF PETROCHEMICAL TECHNOLOGY, SINOPEC
17430068 EXTRACELLULAR MATRIX MODULATING AGENT Final Rejection KOWA COMPANY, LTD.
18240608 Composition Comprising Hueing Agent Non-Final OA Milliken & Company
18441515 ANTI-CANCER COMPOUNDS Final Rejection The University of Sydney
18026211 SOLID STATE FORMS OF GEFAPIXANT AND PROCESS FOR PREPARATION THEREOF Non-Final OA ASSIA CHEMICAL INDUSTRIES LTD.
18349218 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF Non-Final OA Sage Therapeutics, Inc.
18237189 SMALL MOLECULAR INHIBITOR AGAINST BTK AND/OR BTK C481S AND USE THEREOF Non-Final OA ARROMAX PHARMATECH CO., LTD.
18231051 METHOD FOR PREPARING 2-HYDROXY-5-OXOPROLINE Final Rejection Millennium Enterprises, Inc.
18270905 METHOD FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF Non-Final OA ANHUI GUANGXIN AGROCHEMICAL CO., LTD.
18259104 PROCESS FOR THE PRODUCTION OF LACTIDE Non-Final OA POLYWIN PTE. LTD.
18038736 AGROCHEMICAL COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF Non-Final OA PI INDUSTRIES LIMITED
18313723 CRYSTAL FORMS OF TETRAHYDRO-N, N-DIMETHYL-2, 2-DIPHENYL-3-FURANMETHANAMINE, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS Non-Final OA ANAVEX LIFE SCIENCES CORP.
18312894 PESTICIDE COMPOSITION FOR CONTROLLING WHEAT CROWN ROT AND APPLICATION Non-Final OA Institute of Plant Protection and Agro-products Safety, Anhui Academy of Agricultural Sciences
17793191 4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDINE SUMO INHIBITORS AND USES THEREOF Non-Final OA ONCOVALENT THERAPEUTICS INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month